Exchange: NASDAQ·Updated 05:46 AM EDT
SCNI logo

SCNI Scinai Immunotherapeutics Ltd.

$2.15
$0.19
(8.12%)
Pre-Market
Prev Close $2.34
Mkt Cap$133.39M
Vol26,874.00

About SCNI

Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
33

Bearish Sentiment

How do you feel about SCNI?

Advertisement|Remove ads.